文献速递青光眼

COVID-19疫情对原发性开角型青光眼患者降眼压药物依从性的影响

The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma.
PubMed 文献 · Ophthalmology · 2021-10-19

这项队列研究采用受控中断时间序列设计,评估2020年3月13日美国宣布COVID-19疫情前后300天内79例原发性开角型青光眼患者的降眼压药物依从性。结果显示疫情声明后第28天出现依从性斜率断点,此后依从性显著下降(-0.04%/天 vs 之前0.006%/天,P<0.001),且心理韧性评分与斜率变化正相关(P=0.002)。

要点

  • 疫情后降眼压药物依从性显著恶化,断点出现在声明后第28天。
  • 断点前黑人患者依从性中位数80.6%显著低于白人97.2%(P=0.0004)。
  • 心理韧性评分越高,疫情前后依从性斜率变化越正向(P=0.002)。

核心结论

  • COVID-19疫情期间降眼压药物依从性恶化,且似与患者心理韧性相关。

研究设计与样本

  • 队列研究,采用受控中断时间序列设计,中断点为2020年3月13日美国宣布COVID-19疫情。
  • 监测期300天(2019年10月16日至2020年8月10日),纳入79例正在使用降眼压药物的原发性开角型青光眼患者。
  • 采用分段回归分析(斜率滞后变化影响模型)比较断点前后依从性斜率,Davies检验比较两斜率。
  • 依从性通过药物事件监测系统药帽客观测量,定义为服用剂量数除以处方剂量数(百分比)。

主要发现

  • 分段回归识别出疫情声明后第28天为断点。
  • 断点后依从性斜率为-0.04%/天,显著异于零(P<0.001),且显著异于断点前斜率0.006%/天(P<0.001)。
  • 断点前黑人患者依从性中位数(IQR)为80.6%(36.2%),显著低于白人患者的97.2%(8.7%)(卡方=15.4,P=0.0004)。
  • Connor-Davidson心理韧性评分与断点前后斜率变化呈显著正相关(P=0.002)。

关键数值与推荐

  • 断点前依从性斜率0.006%/天,断点后-0.04%/天,差异P<0.001。
  • 断点前黑人患者依从性中位数80.6%(IQR 36.2%),白人97.2%(IQR 8.7%),P=0.0004。
  • 心理韧性评分与斜率变化关联P=0.002。

临床怎么用

  • 临床应关注青光眼患者在重大公共卫生事件期间的降眼压药物依从性,尤其对心理韧性较低者。
  • 对黑人患者等依从性基线较差群体,疫情期间需加强用药支持。

局限性

  • 样本量较小(79例),可能限制普遍性。
  • 依从性通过药帽客观测量,但未报告是否评估其他依从性影响因素。
  • 研究仅纳入已参与纵向研究的患者,存在选择偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Emerging evidence suggests that the coronavirus disease 2019 (COVID-19) pandemic is disrupting health behaviors such as medication adherence. The objective of this study was to determine whether adherence to ocular hypotensive medication was affected by the pandemic and to identify factors associated with this change. DESIGN: In this cohort study, we used a controlled interrupted time series design in which the interruption was the declaration of the COVID-19 pandemic in the United States on March 13, 2020. The 300-day monitoring period, which evenly bracketed this declaration, started on October 16, 2019, and ended on August 10, 2020. PARTICIPANTS: Patients with primary open-angle glaucoma enrolled in an ongoing longitudinal National Institutes of Health-funded study initiated before the onset of the pandemic were selected if they were prescribed ocular hypotensive medication and had adherence data spanning the 300-day period. METHODS: We applied segmented regression analysis using a "slope change following a lag" impact model to obtain the adherence slopes in the periods before and after the segmentation. We compared the 2 slopes using the Davies test. MAIN OUTCOME MEASURES: The main outcome measure was daily adherence to ocular hypotensive medication, defined as the number of doses taken divided by the number of doses prescribed, expressed in percent. Adherence was measured objectively using Medication Event Monitoring System caps. We assessed the associations between change in adherence and demographic, clinical, and psychosocial factors. RESULTS: The sample included 79 patients (mean age, 71 years [standard deviation, 8 years]). Segmented regression identified a breakpoint at day 28 after the declaration of the pandemic. The slope in the period after the breakpoint (-0.04%/day) was significantly different from zero (P < 0.001) and from the slope in the period before the breakpoint (0.006%/day; P < 0.001). Mean adherence in the period before the segmentation breakpoint was significantly worse in Black patients (median, IQR: 80.6%, 36.2%) compared with White patients (median, IQR: 97.2%, 8.7%; chi-square, 15.4; P = 0.0004). A significant positive association was observed between the Connor-Davidson resilience score and the change in slope between the periods before and after the breakpoint (P = 0.002). CONCLUSIONS: Adherence to ocular hypotensive medication worsened during the COVID-19 pandemic and seems to be related to patient resilience. This collateral consequence of the pandemic may translate into vision loss that may manifest beyond its containment.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Racette L, Abu SL, Poleon S, et al. The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma. Ophthalmology. 2021. PMID: 34673098. doi:10.1016/j.ophtha.2021.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。